Apotheek Verse SRL
Apotheek Verse reported total assets of 98,336 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Aug 2026).
The score of Apotheek Verse shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Verse's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Aug 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 01 Jun 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
Apotheek Verse's financial analysis
- Solvency-65.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Verse
Apotheek Verse's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0893.942.595
- VAT number
- BE0893942595
- Peppol
- Registered · 0208:0893942595 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Dec 2007
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 13 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Verse (SRL) has been based in Brussels since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 5,699 € and equity of −64,381 €; its revenue is not published. Its solvency stands at -65.5%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Verse
Companies in the same business, of comparable size and area, outside its group.
- Selvipharma Retail sale of pharmaceutical products Brussels · balance sheet 109,734 €
- Societe Pharmaceutique de Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
- Mencina Retail sale of pharmaceutical products Antwerp · balance sheet 99,620 €
- Stelieco Retail sale of pharmaceutical products Brasschaat · balance sheet 96,802 €
- APVL Retail sale of pharmaceutical products Bornem · balance sheet 96,516 €
- Ingrid Luyten Retail sale of pharmaceutical products Turnhout · balance sheet 100,696 €
- J. Veys Pharma Retail sale of pharmaceutical products Waregem · balance sheet 94,994 €
- Philexis Retail sale of pharmaceutical products Kraainem · balance sheet 101,847 €
Frequently asked questions about Apotheek Verse
What is the revenue of Apotheek Verse?
Apotheek Verse files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Verse?
In Belgium, the VAT number is the company number prefixed with BE: BE0893942595 for Apotheek Verse, if the company is VAT-registered. Its company number (CBE) is 0893.942.595.
Where is the registered office of Apotheek Verse?
According to the CBE register, the registered office of Apotheek Verse is in 1000 Brussels.
What is the equity of Apotheek Verse?
At the close of the 2025 financial year, the equity of Apotheek Verse amounts to -64,381 €, a solvency of -65.5% of total assets.
Who manages Apotheek Verse?
The register lists 1 active mandates at Apotheek Verse. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Verse
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →